F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to cross check discharge medications according
to the facility policy for one of four residents (Resident 4), when a Licensed Vocational Nurse (LVN 1)
improperly transferred Resident 4's Atorvastatin (a medication intended to lower cholesterol and prevent
strokes, heart attacks, and chest pain), as well as Eliquis (a blood thinner that reduces blood clotting) to the
caregiver of Resident 1 during discharge, despite Resident 1 not being prescribed these medications.
Residents Affected - Few
This failure led to the loss of medications and increased the risk of a stroke for Resident 4, while also
exposing Resident 1 to potential adverse effects from the medications, which could result in injury and
harm.
Findings:
During a review of Resident 4's clinical record, the face sheet (contains demographic and medical
information), indicated Resident 4 was admitted on [DATE], with diagnoses that included hypertensive heart
disease with heart failure (the heart is failing to pump blood effectively, and this is due to long-term high
blood pressure).
During a review of the clinical record for Resident 4 ' s the Brief Interview for Mental Status (BIMSscreening tool to identify and monitor cognitive decline), dated March 12,2025, indicated, Resident 4 ' s
score was a 13, which indicated Resident 4 had no mental impairment.
During a review of Resident 1's clinical record, the face sheet (contains demographic and medical
information), indicated Resident 1 was admitted on [DATE], with diagnoses that included Encephalopathy (a
change in how your brain functions), Cirrhosis of Liver (a lot of scars on your liver making it hard for the liver
to do its job).
During a review of the clinical record for Resident 1 ' s the Brief Interview for Mental Status (BIMSscreening tool to identify and monitor cognitive decline), dated March 12,2025, indicated, Resident 1 ' s
score was a 12, which indicated Resident 1 had moderate cognitive impairment (there are significant
changes in thinking and memory that begin to interfere with daily life and independence).
During a concurrent telephone interview and record review on May 16, 2025, at 10:46 PM, with the LVN 1,
the LVN 1 stated on the day of discharge, she inadvertently provided two medication carts belonging to
Resident 4 to the caregiver of Resident 1, who had come to pick up Resident 1. She handed over two carts,
one of which contained Atorvastatin, while she overlooked the other medication. She further stated that the
Social Worker Director (SWD 1) later reported that the family indicated the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
055213
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055213
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Rialto Post Acute Center
1471 S Riverside Ave
Rialto, CA 92376
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
second medication was Eliquis. She acknowledged her mistake and recognized that it was unacceptable.
During a review of the medication records for Residents 1 and 4, she confirmed that Resident 1 is not
prescribed Atorvastatin or Eliquis, whereas Resident 4 is.
During a review of Resident 4 ' s Medical Administration Record (MAR) for May of 2025, it was noted that
Atorvastatin Calcium oral tablet 40 mg (a unit of measurement of mass in the metric system) is prescribed
to be taken as one tablet by mouth at bedtime to manage hyperlipidemia (a condition marked by elevated
lipid levels in the bloodstream). Additionally, Eliquis oral tablet 2.5 mg (Apixaban) is to be administered as
one tablet by mouth twice daily for the prophylaxis (intervention measure) of deep vein thrombosis (a
condition characterized by the formation of a blood clot in a major vein, typically in the leg).
During a review of Resident 1 ' s MAR for May 2025, it was noted that neither Atorvastatin nor Eliquis was
included in the list of prescribed medications for Resident 1.
During a telephone interview on May 16, 2025, at 11:14 PM with the SWD 1, the SWD 1 stated that the
sister of Resident 1 reported that Resident 1 was sent home with medications that were prescribed to
another resident, specifically Atorvastatin and Eliquis, which Resident 1 does not take. Upon receiving this
information, she immediately notified the Director of Nursing (DON 1).
During a telephone interview on May 16, 2025, at 11:21 PM with DON 1, DON 1 stated that resident 1 was
discharged on Friday along with the medications of Resident 4, specifically Atorvastatin and Eliquis. She
indicated that she had reached out to the family, who were under the impression that Resident 1 had been
administered Eliquis during his stay at the facility, which led them to take Resident 1 to the hospital due to
noticeable bruising on his skin. She assured the family that Resident 1 had never received the medications
while in the facility, as it had not been prescribed. She emphasized that LVN 1 ' s failure to verify the
medications is unacceptable.
During a concurrent telephone interview and record review on May 16, 2025, at 1:48 PM, with DON 1, the
facility Policy & Procedure (P&P) titled, Discharge Summary and Plan, dated December 2016 was
reviewed. The P&P indicated, .3. As part of the discharge summary, the nurse will reconcile all
pre-discharge medication with the resident's post-discharge medications. The medication reconciliation will
be documented . DON 1 confirmed the accuracy of policy as outlined.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055213
If continuation sheet
Page 2 of 2